Fluvoxamine as a Treatment for Long COVID-19: A Randomized Placebo Controlled Trial
NCT05874037 · COMPLETED · Phase 3
ReadTheTrial indexes 1 studies for Long Covid. The most common development stage is Phase 3 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
1 clinical trials found for Long Covid.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 3 | 1 | 100% |
There are 1 clinical trials listed for Long Covid. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Long Covid trials are distributed across: Phase 3 (1).